Investor profile
UPMC Enterprises has backed 3 European tech companies across 5 funding rounds between 2020 and 2025, joining rounds totalling €302M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Noema Pharma | Switzerland | 2 | €134M |
| Sparingvision | France | 2 | €120M |
| Ultromics | UK | 1 | €48M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Noema Pharma | Series B | €105M | 2023-03 |
| Sparingvision | Series B | €75M | 2022-09 |
| Ultromics | Series C | €48M | 2025-07 |
| Sparingvision |
| Other |
| €45M |
| 2020-10 |
| Noema Pharma | Series B | €29M | 2024-12 |
